ASX:MVPMedical Developments International Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medical Developments International Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$7.63 +0.06 (+0.79 %) (As of 05/13/2020) Add Compare Share Today's RangeA$7.17Now: A$7.63▼A$7.6650-Day RangeA$3.92MA: A$7.06▼A$8.2452-Week RangeA$3.76Now: A$7.63▼A$11.78Volume169,499 shsAverage VolumeN/AMarket Capitalization$500.58 millionP/E Ratio448.82Dividend Yield0.52%BetaN/A ProfileAdvanced ChartCompetitorsDividendInsider TradesHeadlines Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment in Australia and internationally. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians. Medical Developments International Limited is headquartered in Scoresby, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Medical Developments International. Previous Next 2.5 Community Rank Outperform VotesMedical Developments International has received 14 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMedical Developments International has received 14 “underperform” votes. (Add your “underperform” vote.)Community SentimentMedical Developments International has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Medical Developments International and other stocks. Vote “Outperform” if you believe MVP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MVP will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipMedical Developments International is a leading dividend payer. It pays a dividend yield of 0.52%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthMedical Developments International does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Medical Developments International is 235.29 %. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medical Developments International insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Medical Developments International are expected to decrease by -100.00% in the coming year, from A$0.06 to A$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medical Developments International is 448.82, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 13.79.Price to Earnings Ratio vs. SectorThe P/E ratio of Medical Developments International is 448.82, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.18.Price to Book Value per Share RatioMedical Developments International has a P/B Ratio of 11.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.83 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolASX:MVP Previous Symbol CUSIPN/A CIKN/A Webwww.medicaldev.com Phone61 3 9547 1888Debt Debt-to-Equity Ratio7.99 Current Ratio3.74 Quick Ratio3.22Price-To-Earnings Trailing P/E Ratio448.82 Forward P/E Ratio119.71 P/E GrowthN/A Sales & Book Value Annual Sales$22.25 million Price / Sales22.50 Cash FlowA$0.36 per share Price / Cash Flow21.37 Book ValueA$0.69 per share Price / Book11.14Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees55 Outstanding Shares65,607,300Market Cap$500.58 million Next Earnings DateN/A OptionableNot Optionable Receive MVP News and Ratings via Email Sign-up to receive the latest news and ratings for MVP and its competitors with MarketBeat's FREE daily newsletter. Medical Developments International (ASX:MVP) Frequently Asked Questions How has Medical Developments International's stock been impacted by COVID-19 (Coronavirus)? Medical Developments International's stock was trading at A$6.48 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MVP stock has increased by 17.7% and is now trading at A$7.63. View which stocks have been most impacted by Coronavirus. How often does Medical Developments International pay dividends? What is the dividend yield for Medical Developments International? Medical Developments International announced a Interim dividend on Thursday, February 20th. Shareholders of record on Friday, April 17th will be paid a dividend of 0.02 per share on Friday, April 17th. This represents a yield of 0.18%. The ex-dividend date of this dividend is Thursday, March 5th. View Medical Developments International's dividend history. Has Medical Developments International been receiving favorable news coverage? Media headlines about MVP stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medical Developments International earned a news impact score of 0.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutMedical Developments International. Who are some of Medical Developments International's key competitors? Some companies that are related to Medical Developments International include Opthea (OPT), Mayne Pharma Group (MYX), Vectura Group (VEC), BEXIMCO PHARMAC/S GDR REGS (BXP), Eco Animal Health Group (EAH), Allergy Therapeutics (AGY), Trilogy International Partners (TRL), Recce Pharmaceuticals (RCE), Futura Medical (FUM), NanoViricides (NNVC), Vita Life Sciences (VLS), Pharmaxis (PXS), Avivagen (VIV), Antisense Therapeutics (ANP) and China Pharma (CPHI). View all competitors. What other stocks do shareholders of Medical Developments International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Developments International investors own include Talon Petroleum (TPD), Mesoblast (MESO), Gold Road Resources (GOR), Elixinol Global (ELLXF), Core Lithium (CXO) and Bubs Australia (BUB). Who are Medical Developments International's key executives? Medical Developments International's management team includes the following people: Mr. John Stewart Sharman, Chief Exec. Officer (Age 53)Mr. Mark Edwards, CFO & Company Sec.Dr. Scott Courtney, Director of Research & OperationsMichelle Bradney, Head of Medical AffairsWai Ng Chi, Head of Regulatory Affairs What is Medical Developments International's stock symbol? Medical Developments International trades on the ASX under the ticker symbol "MVP." What is Medical Developments International's stock price today? One share of MVP stock can currently be purchased for approximately A$7.63. How big of a company is Medical Developments International? Medical Developments International has a market capitalization of $500.58 million and generates $22.25 million in revenue each year. Medical Developments International employs 55 workers across the globe. What is Medical Developments International's official website? The official website for Medical Developments International is www.medicaldev.com. How can I contact Medical Developments International? The company can be reached via phone at 61 3 9547 1888. This page was last updated on 5/25/2020 by MarketBeat.com Staff
